Woodward Laboratories was founded in 1992 in the home of Dr. Kenneth Gerenraich, DPM with his initial formulation designed to treat toe and fingernail fungus. He was soon joined by Dr. Daniel Chodosh, a scientist and pioneer in transdermal delivery systems and together they further refined their discovery. The company gained immediate success and professional endorsement with its initial product, Mycocide NS. Today, Mycocide NS is a top category seller in the footcare section of independent pharmacies and drug and retail chains nationwide.

Recognized as the world’s foremost manipulator of quaternary amines, Woodward Laboratories is the first company to research, develop, manufacture, and market over-the-counter (OTC), topically applied antimicrobial products which kill fungi, bacteria, and viruses and are non-damaging to the skin and nails. By focusing on this core competency, the company has grown and established its world headquarters in Orange County, CA, an area rich in pharmaceutical, medical, and other life science industries. Today, the company’s many products serve the consumer, beauty medical, veterinary, and institutional market places with antimicrobial products designed to provide a healthier way of living. The company’s most recent innovation includes a patented capacitive sensor whose many applications are emerging as a key driver for future growth and diversification; and will provide a strong opportunity for leveraging existing product lines.